Skip to main content
. 2017 Jun 10;8(3):241–248. doi: 10.5306/wjco.v8.i3.241

Table 3.

Fertility Preservation options for reproductive age women with breast cancer

Fertility preservation option Current status Advantages Disadvantages
Embryo Cryopreservation Established Highest cumulative pregnancy rates Requires about two weeks delay in the initiation of cancer treatment
Requires hormonal stimulation for oocyte retrieval
Requires in vitro fertilization with male partner or donor sperm
Oocyte Cryopreservation Established No need for male partner or sperm donor Requires about two weeks delay in the initiation of cancer treatment
Requires hormonal stimulation for oocyte retrieval
Ovarian Tissue Cryopreservation and Transplantation Currently experimental, may change as success rates are rising No need for hormonal stimulation Requires outpatient laparoscopic surgery for ovarian tissue harvesting and subsequent transplantation
No need to significantly delay in the initiation of chemotherapy
No need for male partner or sperm donor